TNF and inflammatory bowel disease: Kawamoto et al. indicated that ubiquitination is a process controlled by NOTCH and TNF-α pathways and that infliximab (TNF-α inhibitor) therapy in the course of inflammatory bowel diseases results in a reduction of UBD at the protein level [77].